Skip to main content
. 2017 Oct 4;18:458. doi: 10.1186/s13063-017-2207-x

Table 1.

Participant, PICC insertion and treatment characteristics at randomisation*

Group 1
SPU + SSD+ CHG
Group 2
PAL+ CHG + Tape
Group 3
CSD+ CHG
Group 4
TA + SPU
At recruitment (N = 124) (n = 40) (n = 5) (n = 43) (n = 36)
Age (years)a 56 (16) 63 (20) 57 (15) 54 (18)
Sex (male) 25 (62) 2 (40) 27 (63) 25 (69)
Overweight/obese (n = 102) 20 (62) 2 (50) 21 (58) 16 (53)
Skin integrity:
 - good 13 (32) 1 (20) 13 (30) 14 (39)
 - fair 21 (52) 3 (60) 26 (60) 18 (50)
 - poor 6 (15) 1 (20) 4 (9) 4 (11)
Skin type (white) 32 (80) 3 (60) 30 (70) 26 (72)
Comorbidities 31 (78) 4 (80) 32 (74) 21 (58)
 - none 3 (8) 1 (20) 4 (9) 5 (14)
 - one 6 (15) 0 (0) 7 (16) 10 (28)
 - two 6 (15) 1 (20) 7 (16) 5 (14)
 - three 6 (15) 1 (20) 6 (14) 2 (6)
 - four or more 19 (48) 2 (40) 19 (44) 14 (39)
Diagnosis:
 - medical 10 (25) 1 (20) 14 (33) 10 (28)
 - surgical emergency 9 (22) 2 (40) 11 (26) 8 (22)
 - surgical elective 8 (20) 0 (0) 6 (14) 8 (22)
 - haematology 4 (10) 1 (20) 4 (9) 7 (19)
 - oncology 5 (12) 1 (20) 3 (7) 3 (8)
 - surgical oncology 4 (10) 0 (0) 5 (12) 0 (0)
Leucocytes lowb 1 (2) 0 (0) 0 (0) 0 (0)
Infection (any) 23 (58) 4 (80) 24 (56) 20 (56)
Antibiotic therapy: 31 (78) 5 (100) 30 (70) 28 (78)
 - intravenous 31 (78) 3 (60) 29 (67) 27 (75)
 - oral 1 (2) 3 (60) 8 (19) 4 (11)
At PICC insertion (N = 121) (n = 39) (n = 5) (n = 42) (n = 35)
PICC type (n = 120):
 - basilic 35 (92) 5 (100) 34 (81) 33 (94)
 - brachial 2 (5) 0 (0) 5 (12) 1 (3)
 - cephalic 1 (3) 0 (0) 3 (7) 1 (3)
Subsequent insertion 11 (28) 0 (0) 12 (29) 8 (23)
Inserted by:
 - nurse 36 (92) 5 (100) 35 (83) 31 (89)
 - radiographer 3 (8) 0 (0) 7 (17) 3 (9)
 - doctor 0 (0) 0 (0) 0 (0) 1 (3)
Insertion method:
 - ultrasound 27 (69) 5 (100) 32 (76) 22 (63)
 - ultrasound, fluoroscopy 12 (31) 0 (0) 10 (24) 13 (37)
Multiple insertion attempts 5 (13) 1 (20) 3 (7) 5 (14)
Hair, before insertion: 4 (10) 0 (0) 10 (24) 8 (23)
 - if yes, clippedc 2 - 1 2
Inserted on dominant side 20 (51) 3 (60) 22 (52) 19 (54)
Number of lumens (two)d 27 (69) 1 (20) 31 (74) 23 (66)
Treatment (N = 121) (n = 39) (n = 5) (n = 42) (n = 35)
IV fluids/medicationse:
 - fluid continuous 29 (74) 4 (80) 31 (74) 31 (89)
 - normal saline flush 11 (28) 2 (40) 5 (12) 3 (9)
 - chemotherapy 3 (8) 1 (20) 3 (7) 6 (17)
 - PN (non-lipid) 6 (15) 0 (0) 8 (19) 5 (14)
 - lipids 7 (18) 0 (0) 6 (14) 4 (11)
 - blood products 11 (28) 2 (40) 7 (17) 8 (23)
 - antibiotics 31 (79) 2 (40) 28 (67) 29 (83)
 - heparin, continuous 5 (13) 0 (0) 2 (5) 5 (14)
Patient confused/agitated/drowsy (n = 119)f 1 (3) 0 (0) 6 (15) 4 (12)
Ventilated/intubated (n = 119)f 1 (3) 0 (0) 1 (2) 0 (0)
Independently mobile (n = 119)f 22 (56) 3 (60) 25 (61) 21 (62)
Other VAD in situf 2 (5) 0 (0) 9 (21) 9 (26)

*Data presented on 124 randomised patients and 121 inserted peripherally inserted central catheters (PICCs); number (percentage) shown unless otherwise noted. Frequencies may not add up to group size (and frequencies to 100%) due to missing data

SPU simple polyurethane dressing, SSD sutureless securement device, CHG chlorhexidine gluconate-impregnated discs, PAL polyurethane with absorbent lattice pad dressing, CSD combination securement dressing, TA tissue adhesive, VAD vascular access device, PN parenteral nutrition

aMean (standard deviation) shown

bAbsolute value <1000 per microlitre

cFrequencies shown only

dOther categories omitted

eReceived at any time during the study period

fAt device removal